Follow
Alejandra Pera
Alejandra Pera
Department of Immunology, Maimonides Institute for Biomedical Research (IMIBIC)
Verified email at uco.es
Title
Cited by
Cited by
Year
Immunosenescence: implications for response to infection and vaccination in older people
A Pera, C Campos, N López, F Hassouneh, C Alonso, R Tarazona, ...
Maturitas 82 (1), 50-55, 2015
3992015
Immunosenescence of human natural killer cells
I Gayoso, B Sanchez-Correa, C Campos, C Alonso, A Pera, JG Casado, ...
Journal of innate immunity 3 (4), 337-343, 2011
2062011
CMV and Immunosenescence: from basics to clinics
R Solana, R Tarazona, AE Aiello, AN Akbar, V Appay, M Beswick, ...
Immunity & Ageing 9, 1-9, 2012
1992012
DNAM-1 and the TIGIT/PVRIG/TACTILE axis: novel immune checkpoints for natural killer cell-based cancer immunotherapy
B Sanchez-Correa, I Valhondo, F Hassouneh, N Lopez-Sejas, A Pera, ...
Cancers 11 (6), 877, 2019
1792019
NK cells in healthy aging and age-associated diseases
X Camous, A Pera, R Solana, A Larbi
BioMed Research International 2012, 2012
1572012
Shaping of NK cell subsets by aging
R Solana, C Campos, A Pera, R Tarazona
Current opinion in immunology 29, 56-61, 2014
1442014
Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA
A Pera, S Dossena, S Rodighiero, M Gandía, G Bottà, G Meyer, F Moreno, ...
Proceedings of the National Academy of Sciences 105 (47), 18608-18613, 2008
1302008
CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals
A Pera, C Campos, A Corona, B Sanchez-Correa, R Tarazona, A Larbi, ...
PloS one 9 (2), e88538, 2014
1242014
Effect of age and CMV on NK cell subpopulations
C Campos, A Pera, B Sanchez-Correa, C Alonso, I Lopez-Fernandez, ...
Experimental gerontology 54, 130-137, 2014
1222014
Expansions of Cytotoxic CD4+CD28 T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are …
I Broadley, A Pera, G Morrow, KA Davies, F Kern
Frontiers in immunology 8, 195, 2017
892017
A mutational analysis of the SLC26A4 gene in Spanish hearing-impaired families provides new insights into the genetic causes of Pendred syndrome and DFNB4 hearing loss.
A Pera, M Villamar, A Vinuela, M Gandía, C Meda, F Moreno, ...
European Journal of Human Genetics 16 (8), 888-896, 2008
752008
De novo mutation in the gene encoding connexin‐26 (GJB2) in a sporadic case of keratitis‐ichthyosis‐deafness (KID) syndrome
A Álvarez, I del Castillo, A Pera, M Villamar, MA Moreno‐Pelayo, ...
American journal of medical genetics Part A 117 (1), 89-91, 2003
572003
Proinflammatory status influences NK cells subsets in the elderly
C Campos, A Pera, I Lopez-Fernandez, C Alonso, R Tarazona, R Solana
Immunology letters 162 (1), 298-302, 2014
562014
CD28 null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection
A Bano, A Pera, A Almoukayed, THS Clarke, S Kirmani, KA Davies, ...
F1000Research 8, 2019
492019
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
B Sanchez-Correa, C Campos, A Pera, JM Bergua, MJ Arcos, H Bañas, ...
Cancer immunology, immunotherapy 65, 453-463, 2016
482016
CMV induces expansion of highly polyfunctional CD4+ T cell subset coexpressing CD57 and CD154
A Pera, A Vasudev, C Tan, H Kared, R Solana, A Larbi
Journal of Leucocyte Biology 101 (2), 555-566, 2017
452017
CD28null pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death
A Pera, S Caserta, F Albanese, P Blowers, G Morrow, N Terrazzini, ...
Theranostics 8 (16), 4509, 2018
442018
Current progress in NK cell biology and NK cell-based cancer immunotherapy
R Tarazona, N Lopez-Sejas, B Guerrero, F Hassouneh, I Valhondo, ...
Cancer Immunology, Immunotherapy 69, 879-899, 2020
432020
Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age
C Campos, N López, A Pera, JJ Gordillo, F Hassouneh, R Tarazona, ...
Biogerontology 16, 671-683, 2015
422015
Immunosenescence: limitations of natural killer cell-based cancer immunotherapy
R Tarazona, B Sanchez-Correa, I Casas-Avilés, C Campos, A Pera, ...
Cancer Immunology, Immunotherapy 66, 233-245, 2017
392017
The system can't perform the operation now. Try again later.
Articles 1–20